John H. Dodd
29Patents
8h-index
28Co-inventors
75Inventor score
Filing activity: Dec 20, 1985 → Jan 11, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5075440A | Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines | Human Necessities | 11 | Expired |
| US6472530B1 | Benzo-fused dithiepino[6,5-b]pyridines, and related compositions and methods | Human Necessities | 11 | Expired |
| US4672116A | Substituted 5,6-dialkoxyquinazoline derivatives | Human Necessities | 10 | Expired |
| US4879384A | Preparation of thiocycloalkno [3,2-b] pyridines | Chemistry; Metallurgy | 9 | Expired |
| US4705785A | Substituted thiacycloalkeno (3,2-b) pyridines and pharmaceutical compositions and method of use | Human Necessities | 8 | Expired |
| US6903109B2 | Arylindenopyridines and related therapeutic and prophylactic methods | Chemistry; Metallurgy | 8 | Expired |
| US4845225A | Substituted thiacycloalkeno [3,2-b] pyridines | Chemistry; Metallurgy | 8 | Expired |
| US6958328B2 | Arylindenopyridines and related therapeutic and prophylactic methods | Chemistry; Metallurgy | 8 | Expired |
| US8263608B2 | Melanocortin receptor-specific spiro-piperidine compounds | Human Necessities | 8 | Active |
| US8455617B2 | Melanocortin receptor-specific peptides | Human Necessities | 5 | Active |
| US8846601B2 | Melanocortin receptor-specific peptides | Emerging Cross-Sectional Technologies | 4 | Active |
| US6291454A | Dithiepino[6,5-b]pyridines, and related compositions and methods | Human Necessities | 4 | Expired |
| US6147096A | Substituted pyrrolobenzimidazoles for treating inflammatory diseases | Human Necessities | 4 | Expired |
| US4745123A | Substituted tetrahydro-3-pyridine-carboxylic acid, ester, and amide cholinergic agents | Chemistry; Metallurgy | 3 | Expired |
| US6469174B1 | Substituted pyrrolobenzimidazoles for treating inflammatory diseases | Human Necessities | 3 | Expired |
| US9040663B2 | Melanocortin receptor-specific peptides | Human Necessities | 3 | Active |
| US6610697B1 | Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods | Human Necessities | 2 | Expired |
| US8455618B2 | Melanocortin receptor-specific peptides | Human Necessities | 2 | Active |
| US5834521A | Substituted dibenz (A F)azulenes and methods of preparation | Chemistry; Metallurgy | 1 | Expired |
| US4777167A | Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines, compositions and method of use | Human Necessities | 1 | Expired |
| US10106552B2 | Compounds inhibiting eukaryotic elongation factor 2 kinase activity | Chemistry; Metallurgy | 0 | Active |
| US6410552B1 | Benzoether and related compositions and methods | Human Necessities | 0 | Expired |
| US10179804B2 | Melanocortin receptor-specific peptides | Emerging Cross-Sectional Technologies | 0 | Active |
| US10660939B2 | Therapies for obesity, diabetes and related indications | Human Necessities | 0 | Active |
| US6410553B1 | Benzosulfones and related compositions and methods | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.